N@N

AtriCure Announces Upcoming Investor Conference Schedule

^{Published on 2011-11-10 08:57:01 - Market Wire}
 

WEST CHESTER, Ohio--([ BUSINESS WIRE ])--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, today announced that it will participate in the following upcoming investor conferences:

• The Lazard Capital Markets 8^th Annual Healthcare Conference at the Pierre Hotel in New York. Management is scheduled to present on November 16, 2011 at 2:00 p.m. Eastern Time.
• The 23^rd Annual Piper Jaffray Healthcare Conference at The New York Palace Hotel. Management is scheduled to present on November 30, 2011 at 10:00 a.m. Eastern Time.
• The Canaccord Genuity 6^th Annual Cardiovascular, Aesthetics & Metabolic Disorders Med-tech Conference at the St. Regis Hotel in San Francisco. Management is scheduled to present on December 6, 2011 at 2:40 p.m. Pacific Time.

A live audio webcast and replay of the presentations will be available for 30 days following the events at [ www.atricure.com ].

About AtriCure, Inc.

AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue and systems for the exclusion of the left atrial appendage. For more information, please visit [ www.atricure.com ].